Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Oncol. Feb 15, 2014; 6(2): 34-40
Published online Feb 15, 2014. doi: 10.4251/wjgo.v6.i2.34
Published online Feb 15, 2014. doi: 10.4251/wjgo.v6.i2.34
Thrombocytosis as a prognostic marker in gastrointestinal cancers
Ioannis A Voutsadakis, Division of Medical Oncology, Sault Area Hospital, Sault Ste Marie, Ontario P6B 0A8, Canada
Author contributions: Voutsadakis IA contributed solely this paper.
Correspondence to: Ioannis A Voutsadakis, MD, PhD, Division of Medical Oncology, Sault Area Hospital, 750 Great Northern Road, Sault Ste Marie, Ontario P6B 0A8, Canada. ivoutsadakis@yahoo.com
Telephone: +1-705-7593434 Fax: +1-705-7593815
Received: October 17, 2013
Revised: December 21, 2013
Accepted: January 6, 2014
Published online: February 15, 2014
Revised: December 21, 2013
Accepted: January 6, 2014
Published online: February 15, 2014
Core Tip
Core tip: Thrombocytosis arises as a prognostic factor in various cancers, although it is not clear whether there is a pathogenic contribution or thrombocytosis merely reflects a pro-carcinogenic inflammatory milieu. This paper discusses the utility of thrombocytosis as a prognostic factor in gastrointestinal cancers.